We are live on
!
Find out more
HC
Henshaw Capital Portfolio holdings
AUM
$3.07B
Turnover
11.76%
1-Year Est. Return
40.85%
This Fund
S&P 500
This Quarter
Est. Return
+6.77%
1 Year Est. Return
+40.85%
3 Year Est. Return
+128.2%
5 Year Est. Return
+170.36%
10 Year Est. Return
+567.65%
AUM
$914M
AUM Growth
+$67.7M
(+8%)
Cap. Flow
+$17.1M
Cap. Flow
% of AUM
1.87%
Top 10 Holdings %
Top 10 Hldgs %
31.66%
Holding
292
New
16
Increased
25
Reduced
16
Closed
12
Avg Time Held
0.9
years
Top 10 Avg Time Held
0.9
years
Top 20 Avg Time Held
0.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$6.32M |
| 2 |
JPMorgan Chase
JPM
|
+$3.57M |
| 3 |
Pfizer
PFE
|
+$3.16M |
| 4 |
GSK
GSK
|
+$2.84M |
| 5 |
Nordson
NDSN
|
+$528K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CLC
Clarcor
CLC
|
+$1.39M |
| 2 |
CLNY
Colony Capital, Inc.
CLNY
|
+$454K |
| 3 |
STJ
St Jude Medical
STJ
|
+$393K |
| 4 |
Idexx Laboratories
IDXX
|
+$389K |
| 5 |
Portland General Electric
POR
|
+$334K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 17.03% |
| 2 | Technology | 16.72% |
| 3 | Healthcare | 13.67% |
| 4 | Communication Services | 12.36% |
| 5 | Financials | 9.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
LVLT
151
DELISTED
Level 3 Communications Inc
LVLT
| $450K | 0.05% |
7,858
| – | – |
2016 Q1
4 quarters
|
|
|
CAVM
152
DELISTED
Cavium, Inc.
CAVM
| $443K | 0.05% |
6,183
| – | – |
2016 Q1
4 quarters
|
|
153
Ambev
ABEV
$50.4B
| $438K | 0.05% |
76,125
-7,698
| -9% | -$42.2K |
2016 Q1
4 quarters
|
|
154
Zurn Elkay Water Solutions
ZWS
$7.8B
| $426K | 0.05% |
38,356
| – | – |
2016 Q1
4 quarters
|
|
155
Labcorp
LH
$25.8B
| $426K | 0.05% |
3,459
| – | – |
2016 Q1
4 quarters
|
|
156
DELISTED
DigitalBridge
DBRG
| $424K | 0.05% |
+8,220
| New | +$462K |
2017 Q1
0 quarters
|
|
|
TTM
157
DELISTED
Tata Motors Limited
TTM
| $423K | 0.05% |
+11,856
| New | +$433K |
2017 Q1
0 quarters
|
|
158
Merck
MRK
$360B
| $419K | 0.05% |
6,917
| – | – |
2016 Q1
4 quarters
|
|
159
Wells Fargo
WFC
$252B
| $419K | 0.05% |
7,531
| – | – |
2016 Q1
4 quarters
|
|
160
BHP
BHP
$212B
| $419K | 0.05% |
12,928
| – | – |
2016 Q1
4 quarters
|
|
161
Broadcom
AVGO
$1.57T
| $419K | 0.05% |
19,130
-4,390
| -19% | -$90.4K |
2016 Q1
4 quarters
|
|
162
DELISTED
Unilever NV New York Registry Shares
UN
| $416K | 0.05% |
8,381
| – | – |
2016 Q1
4 quarters
|
|
163
Fortinet
FTNT
$124B
| $416K | 0.05% |
54,270
| – | – |
2016 Q1
4 quarters
|
|
164
Silicon Laboratories
SLAB
$7.38B
| $409K | 0.04% |
5,555
| – | – |
2016 Q1
4 quarters
|
|
165
DELISTED
Du Pont De Nemours E I
DD
| $406K | 0.04% |
5,060
| – | – |
2016 Q1
4 quarters
|
|
166
Accenture
ACN
$141B
| $406K | 0.04% |
+3,383
| New | +$404K |
2017 Q1
0 quarters
|
|
167
Aegon
AEG
$12.3B
| $405K | 0.04% |
102,729
| – | – |
2016 Q1
4 quarters
|
|
168
Columbia Banking Systems
COLB
$8.04B
| $405K | 0.04% |
10,395
| – | – |
2016 Q1
4 quarters
|
|
169
Intuit
INTU
$86.9B
| $401K | 0.04% |
3,460
| – | – |
2016 Q1
4 quarters
|
|
170
Principal Financial Group
PFG
$23.3B
| $401K | 0.04% |
6,358
| – | – |
2016 Q1
4 quarters
|
|
171
Gildan
GIL
$7.58B
| $400K | 0.04% |
14,782
| – | – |
2016 Q3
2 quarters
|
|
172
NetEase
NTES
$80.7B
| $396K | 0.04% |
6,975
| – | – |
2016 Q1
4 quarters
|
|
|
NLSN
173
DELISTED
Nielsen Holdings plc
NLSN
| $394K | 0.04% |
9,533
+2,858
| +43% | +$122K |
2016 Q1
4 quarters
|
|
174
HDFC Bank
HDB
$123B
| $393K | 0.04% |
20,884
| – | – |
2016 Q1
4 quarters
|
|
|
WSTC
175
DELISTED
West Corporation
WSTC
| $392K | 0.04% |
16,053
| – | – |
2016 Q1
4 quarters
|
|
Similar funds
Henshaw Capital's Q1 2017 Portfolio in Review
As of Q1 2017, Henshaw Capital held 292 positions worth $914M, up 8% from $847M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Henshaw Capital's Q1 2017 filing shows 16 new, 25 increased, 16 reduced and 12 closed positions. Its largest new stake was Nordson: 4,459 shares worth $548K. The largest sale was Clarcor, an estimated $1.39M.
By sector, the portfolio is most concentrated in Industrials at 17% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
- Henshaw Capital's largest Q1 2017 buy was Nordson: 4,459 shares worth $548K.
- Henshaw Capital added most to Vanguard FTSE Emerging Markets ETF in Q1 2017, an estimated $6.32M increase.
- Henshaw Capital's biggest Q1 2017 reduction was Idexx Laboratories, cutting an estimated $389K.
- Henshaw Capital fully exited Clarcor in Q1 2017, selling an estimated $1.39M.
- Henshaw Capital's ten largest holdings make up 32% of its $914M portfolio in Q1 2017.
- Henshaw Capital opened 16 new positions and closed 12 in Q1 2017.
- Henshaw Capital's portfolio value rose 8% quarter-over-quarter to $914M.
Based on Henshaw Capital's 13F filing for Q1 2017, filed 28 May 2026.